合并主动脉瓣与二尖瓣反流患者的心脏重构与结局
多中心观察性研究纳入915例心脏磁共振显示中度或重度主动脉瓣反流患者,27.4%合并二尖瓣反流,中位随访3.0年。合并至少中度二尖瓣反流与全因死亡风险升高相关(HR 2.77),无症状合并中度主动脉瓣与二尖瓣反流患者在内科监测下死亡和心衰风险更高,值得进一步研究。
要点
- 心脏磁共振显示合并至少中度二尖瓣反流时,主动脉瓣反流每增加一单位程度,心室容积增加更明显且心室功能下降(交互P≤0.01)。
- 合并至少中度二尖瓣反流与全因死亡风险升高相关(HR 2.77,95%CI 1.91-4.01,P<0.001)。
- 无症状或轻微症状的合并中度主动脉瓣与二尖瓣反流患者在内科监测下,主要和次要结局风险均高于单纯主动脉瓣反流。
核心结论
- 心脏磁共振显示合并主动脉瓣与二尖瓣反流较单纯主动脉瓣反流心室重构更重、不良结局风险更高;无症状合并中度主动脉瓣与二尖瓣反流患者在内科监测下死亡和心衰风险更高,值得进一步研究。
研究设计与样本
- 多中心观察性结局研究,纳入915例心脏磁共振显示中度或重度主动脉瓣反流患者,排除既往瓣膜手术、大于轻度瓣膜狭窄、肥厚型或浸润性心肌病及除二叶式主动脉瓣外的先天性心脏病患者,采用倾向性评分匹配比较单纯主动脉瓣反流与合并反流组。
关键影像表现/征象
- 合并至少中度二尖瓣反流(占总人群14.2%)时,主动脉瓣反流严重程度每增加一单位,心室容积增加幅度更大且心室功能下降(交互P≤0.01)。
- 251/915例(27.4%)存在合并二尖瓣反流,中位二尖瓣反流分数为24%(Q1-Q3:17%-35%)。
- 中位随访3.0年(Q1-Q3:1.1-5.6年)期间共152例死亡。
诊断标准与关键数值
- 合并至少中度二尖瓣反流与全因死亡风险升高相关(HR 2.77,95%CI 1.91-4.01,P<0.001)。
- 合并至少中度二尖瓣反流与全因死亡或心衰住院复合结局风险升高相关(HR 2.62,95%CI 1.87-3.67,P<0.001)。
- 无症状或轻微症状患者在内科监测下,合并中度主动脉瓣与中度二尖瓣反流较单纯主动脉瓣反流主要和次要结局风险更高,且独立于年龄、性别、合并症、射血分数和收缩末期容积。
临床应用与阅片要点
- 心脏磁共振评估主动脉瓣反流时,应同时评估二尖瓣反流的存在与程度,合并至少中度二尖瓣反流提示心室重构更重和不良结局风险更高。
- 无症状或轻微症状的合并中度主动脉瓣与二尖瓣反流患者在内科监测下不良结局风险高于单纯主动脉瓣反流,原文结论为值得进一步研究。
局限性
- 原文结论指出无症状合并中度主动脉瓣与二尖瓣反流患者在内科监测下死亡和心衰风险更高,值得进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Management of patients with combined aortic and mitral regurgitation (AR and MR) is largely based on expert opinion. Specifically, the outcomes of patients with combined moderate AR and moderate MR under medical surveillance are uncertain.
OBJECTIVES: This study aimed to evaluate cardiac remodeling using cardiac magnetic resonance (CMR) in patients with combined AR/MR compared with isolated AR, to assess degree of MR associated with adverse outcomes, and evaluate the outcomes of asymptomatic patients with combined moderate AR and moderate MR under medical surveillance.
METHODS: The authors conducted a multicenter observational outcome study of patients with moderate or severe AR on CMR, and evaluated the etiology and degree of concomitant MR in patients with combined AR and MR. They excluded patients if they had prior valvular surgery, > mild valve stenosis, hypertrophic or infiltrative cardiomyopathy, or congenital heart disease except bicuspid aortic valve. The authors evaluated ventricular volumes and function across the spectrum of regurgitation severity. Receiver-operating characteristic analyses for the association of concomitant MR severity with outcomes were performed. The primary outcome was all-cause death. Secondary outcome was all-cause death or heart failure (HF) hospitalization. Patients were censored at the time of valvular surgery or intervention. Propensity score matching was done between isolated AR and the combined AR/MR groups.
RESULTS: The authors studied 915 patients with a median age of 61 years (Q1-Q3: 49-72 years), 79.5% male, 29% with bicuspid aortic valve, and a median AR fraction of 38% (Q1-Q3: 32%-45%). In 251 of 915 patients (27.4%) with concomitant MR, the median MR fraction was 24% (Q1-Q3: 17%-35%). The presence of concomitant ≥moderate MR (14.2% of the total population) was associated with a greater increase in ventricular volumes per unit increase in AR severity, and a decline in ventricular function (P for interaction ≤0.01). During a median follow-up of 3.0 years (Q1-Q3: 1.1-5.6 years), there were 152 deaths. Presence of concomitant ≥moderate MR was associated with an increased hazard for all-cause death (HR: 2.77; 95% CI: 1.91-4.01; P < 0.001), and the secondary outcome of death or HF (HR: 2.62; 95% CI: 1.87-3.67; P < 0.001). In asymptomatic or minimally symptomatic patients undergoing medical surveillance, the presence of combined moderate AR and moderate MR was independently associated with a higher hazard for the primary and secondary outcomes compared with isolated AR, independent of age, sex, comorbidities, ejection fraction, and end-systolic volume. Findings were consistent in the propensity matched cohort.
CONCLUSIONS: The presence of combined AR and MR on CMR is associated with a greater extent of ventricular remodeling and increased hazard for adverse outcomes, compared with isolated AR. Asymptomatic patients with combined moderate AR and MR under medical surveillance are at higher risk for death and HF, and warrant further study.
引用
- Malahfji M, Saeed M, Nguyen DT, et al. Cardiac Remodeling and Outcomes of Patients With Combined Aortic and Mitral Regurgitation. JACC Cardiovasc Imaging. 2025. PMID: 41175121. doi:10.1016/j.jcmg.2025.09.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。